Verona Pharma

AI Score

0

Unlock

65.89
-3.74 (-5.37%)
At close: Mar 03, 2025, 3:59 PM
68.96
4.65%
After-hours: Mar 03, 2025, 04:03 PM EST

Verona Pharma Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Revenue 42.28M n/a 458K 40M n/a 2.35K 2.78K 1.84M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 2.58M 679.62K 346K n/a 627.85K 512.11K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 39.7M -679.62K 112K 40M -627.85K -509.76K 2.78K 1.84M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -154.63M -67.83M -66.12M -73.31M -74.28M -53.87M -32.47M -40.21M -8.66M -13.29M -5.9M -4.64M -4.18M -2.87M -2.93M -2.6M -2.17M -2.61M -1.31M -12.04K
Interest Income 15.26M 12.81M 2.82M 14K 121K 988.62K 1.09M 466.24K 106.78K 66.36K 46.66K 4.34K 32.61K 6.21K 12.35K 11.32K 203.55K 192.36K 123.43K 56.78K
Pretax Income -163.13M -55.21M -68.45M -55.59M -65M -51.41M -30.62M -34.06M -7.37M -13.22M -5.86M -4.64M -4.15M -2.86M -2.91M -2.59M -1.97M -2.41M -1.19M 44.74K
Net Income -173.42M -54.37M -68.7M -55.57M -65.15M -41.88M -25.25M -27.7M -6.19M -10.99M -4.29M -4.16M -4.07M -2.67M -2.92M -2.59M -2.01M -2.41M -1.19M 44.74K
Selling & General & Admin 149.75M 49.87M 26.58M 33.91M 29.77M 8.99M 7.99M 8.1M 2.89M 2.51M 1.8M 1.91M 1.47M 1.12M 1.09M 1.05M 827.39K 894.4K 1.05M 18.93K
Research & Development 44.57M 17.28M 49.28M 79.41M 44.51M 43.89M 24.48M 32.05M 5.58M 10.76M 4.1M 2.73M 2.71M 1.46M 1.78M 1.53M 1.29M 1.5M 266.45K n/a
Other Expenses n/a n/a -9.63M -15.63M -8.27M 527.09K 16.5K 23K 1.07M 1.17M n/a n/a 0.00 268.6K 43.22K 11.32K 61.51K 196.33K n/a -113.57K
Operating Expenses 194.32M 67.15M 66.23M 97.68M 66.01M 53.41M 32.48M 40.16M 8.49M 13.29M 5.9M 4.64M 4.18M 2.87M 2.93M 2.6M 2.17M 2.61M 1.31M 12.04K
Interest Expense -23.54M 2.06M 521K 340K 35K 221.59K n/a 98.65K 104.52K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a 19.38M 22.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 196.91M 67.83M 66.57M 97.68M 66.01M 53.41M 32.48M 40.16M 8.49M 13.29M 5.9M 4.64M 4.18M 2.87M 2.93M 2.6M 2.17M 2.61M 1.31M 12.04K
Income Tax -10.29M -632.44K 253K -18K 146K -9.53M -5.37M -6.36M -1.18M -2.24M -1.56M -477.22K -77.68K -192.52K 7.72K -24.25K 41K 192.36K 123.43K n/a
Shares Outstanding (Basic) 652.31M 604.1M 528.46M 473.18M 262.93M 105.32M 105.1M 87.74M 33.5M 20.19M 17.33M 6.82M 6.13M 6.14M 6.14M 6.14M 6.14M 6.14M 6.14M 6.14M
Shares Outstanding (Diluted) 652.31M 634.14M 529.07M 473.19M 262.93M 105.33M 105.11M 87.75M 33.5M 20.2M 17.33M 6.83M 6.13M 6.14M 6.14M 6.14M 6.14M 6.14M 6.14M 6.14M
EPS (Basic) -0.27 -0.09 -0.13 -0.12 -0.25 -0.4 -0.24 -0.32 -0.18 -0.54 -0.25 -0.61 -0.66 -0.43 -0.48 -0.42 -0.33 -0.39 -0.19 0.01
EPS (Diluted) -0.27 -0.09 -0.13 -0.12 -0.25 -0.4 -0.24 -0.32 -0.18 -0.54 -0.25 -0.61 -0.66 -0.43 -0.48 -0.42 -0.33 -0.39 -0.19 0.01
EBITDA -154.63M -52.47M -67.29M -42.19M -47.81M -32.17M -25.5M -29.64M -6.96M -8.92M -3.74M -2.78M -2.56M -2.86M -2.88M -2.59M -1.94M -2.39M -1.19M -12.04K
Depreciation & Amortization n/a 679.62K 636K 629K 627.85K 512.11K 124.35K 166.22K 76.03K 78.69K 82.43K 61.99K 49.08K 37.26K 32.41K 35.57K 27.82K 27.76K 3.92K n/a